BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8772544)

  • 1. Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.
    Moghetti P; Castello R; Negri C; Tosi F; Spiazzi GG; Brun E; Balducci R; Toscano V; Muggeo M
    J Clin Endocrinol Metab; 1996 Mar; 81(3):881-6. PubMed ID: 8772544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women.
    Tosi F; Negri C; Brun E; Castello R; Faccini G; Bonora E; Muggeo M; Toscano V; Moghetti P
    Eur J Endocrinol; 2011 Feb; 164(2):197-203. PubMed ID: 21059865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin inhibits adrenal 17,20-lyase activity in man.
    Nestler JE; McClanahan MA; Clore JN; Blackard WG
    J Clin Endocrinol Metab; 1992 Feb; 74(2):362-7. PubMed ID: 1730815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of androgen on adrenal steroidogenesis in normal women.
    Vermesh M; Silva PD; Rosen GF; Vijod AG; Lobo RA
    J Clin Endocrinol Metab; 1988 Jan; 66(1):128-30. PubMed ID: 2826523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.
    Nestler JE; Jakubowicz DJ
    N Engl J Med; 1996 Aug; 335(9):617-23. PubMed ID: 8687515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of buserelin testing in the evaluation of hirsute women.
    Ambrosi B; Re T; Passini E; Bochicchio D; Ferrario R
    J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
    Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF; Finegold DN; Lanes R; Lee PA
    N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea.
    Genazzani AD; Bersi C; Luisi S; Fruzzetti F; Malavasi B; Luisi M; Petraglia F; Genazzani AR
    J Steroid Biochem Mol Biol; 2001 Sep; 78(3):247-52. PubMed ID: 11595505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Tosi F; Negri C; Perrone F; Dorizzi R; Castello R; Bonora E; Moghetti P
    J Clin Endocrinol Metab; 2012 May; 97(5):1712-9. PubMed ID: 22419715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Defects of adrenal steroidogenesis in patients with hirsutism].
    Salinas Vert I; Audí Parera L; Granada Ybern ML; Lucas Martín A; Pizarro Lozano E; Foz Sala M; Sanmartí Sala A
    Med Clin (Barc); 1998 Feb; 110(5):171-6. PubMed ID: 9547720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.
    Azziz R; Bradley EL; Potter HD; Boots LR
    J Clin Endocrinol Metab; 1995 Feb; 80(2):400-5. PubMed ID: 7852496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.
    Nestler JE; Jakubowicz DJ
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4075-9. PubMed ID: 9398716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
    Luboshitzky R; Ishai A; Shen-Or Z; Herer P
    Neuro Endocrinol Lett; 2003; 24(3-4):249-54. PubMed ID: 14523365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitus.
    Ueshiba H; Shimizu Y; Hiroi N; Yakushiji F; Shimojo M; Tsuboi K; Miyachi Y
    Eur J Endocrinol; 2002 Mar; 146(3):375-80. PubMed ID: 11888844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha.
    Escobar-Morreale H; Pazos F; Potau N; García-Robles R; Sancho JM; Varela C
    Fertil Steril; 1994 Sep; 62(3):521-30. PubMed ID: 8062947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
    Azziz R; Rafi A; Smith BR; Bradley EL; Zacur HA
    J Clin Endocrinol Metab; 1990 Feb; 70(2):431-6. PubMed ID: 2137133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.
    Nestler JE; Clore JN; Strauss JF; Blackard WG
    J Clin Endocrinol Metab; 1987 Jan; 64(1):180-4. PubMed ID: 2946716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.